In response to the mounting as COVID-19 (coronavirus) crisis, the CSA announced it will provide blanket relief from certain regulatory filings required to be filed on or before June 1, 2020. 

Continuous disclosure relief

The proposed relief will provide a blanket 45-day extension from existing deadlines for periodic filings required to be made by issuers on or before June 1, 2020, including annual financial statements, MD&A and annual information forms. Further details of the relief will be published shortly.

The extension applies to all issuers. For those with a December 31 year-end, the extensions are as follows:

TSX-listed issuers

   Original Deadline New deadline 
Annual filing deadline (year-end financials, MD&A and AIF) March 30 May 14
Q1 filing deadline May 15 June 29


TSX-Venture and CSE-listed issuers

   Original Deadline New deadline 
Annual filing deadline (year-end financials, MD&A and AIF) April 29 June 15
Q1 filing deadline June 1 July 14


The requirement to file a management cease-trade order, announced earlier this week, no longer applies to issuers who will miss a deadline as a result of the coronavirus, provided they comply with the soon-to-be-announced relief conditions.

The relief will allow issuers to focus on critical business decisions surrounding the virus.

Virtual shareholder meetings

In addition, the CSA has indicated it will soon be issuing guidance on annual general meetings in light of issuers considering virtual meetings to mitigate the risk of transmission of the coronavirus.

We will keep you posted as further details become available.


Senior Partner, Canadian Head of Corporate Governance
Senior Partner
Managing Partner, Québec Office
Senior Partner

Recent publications

Subscribe and stay up to date with the latest legal news, information and events . . .